Innovations in Immune-Mediated Skin Conditions Webinar Series
AMCP is producing a series of live, CPE accredited 1-hour webinars in January and February 2023 focusing on evidence-based guidance and real-world implications of the growing treatment landscape for immune-mediated skin conditions.
Multiple skin conditions — including atopic dermatitis and alopecia areata — are caused and/or driven by the immune system as a result of genetic susceptibility, environmental triggers, and activation of inflammatory pathways. Research into the pathogenesis of these conditions has led to the identification of complex immunological pathways that drive disease onset and progression, and contribute to higher disease severity, debilitating comorbidities, and costly complications.
This activity is supported by an unrestricted educational grant from Pfizer, Inc.
Schedule and Registration
Innovations in Immune-Mediated Skin Conditions: Focus on Alopecia Areata
- Tuesday, Jan. 24, 2023, 5:30–6:30 pm EST
- Tuesday, Jan. 31, 2023, 5:30–6:30 pm EST (repeat offering)
During this session, presenters will provide an overview of the disease burden of alopecia areata, discuss health care costs and utilization, highlight the patient-specific factors that must be considered when making treatment decisions for a diverse population, and explore the FDA-approved and pipeline pharmacologic treatment options for alopecia areata.
Learning Objectives
At the completion of this knowledge-based activity, participants should be able to:
1. Describe the disease burden of moderate-to-severe alopecia areata on clinical and patient-reported outcomes.
2. Differentiate new and emerging targeted therapies for alopecia areata based on mechanisms of action, efficacy and safety data, and indications.
3. Discuss approaches to managing alopecia areata among a diverse patient population.
4. Identify strategies to manage health care utilization and costs related to alopecia areata.
Target Audience
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
Faculty
- Loren Krueger, MD, FAAD
Assistant Professor, Dermatology
Vice Chair, Diversity, Equity and Inclusion
Emory University School of Medicine - Steven Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy
Highmark, Inc.
Moderators
- Kellie Rademacher, PharmD
Director Strategy
Evoke Navience - Lynn Deguzman, PharmD, BCGP
Clinical Pharmacy Services Director, National Pharmacy
Kaiser Permanente
Agenda
5:30–5:35 pm — Welcome and Introductions
Moderator
5:35–6:25 pm — Presentation: Innovations in Immune-Mediated Skin Conditions: Focus on Alopecia Areata
- Loren Krueger, MD, FAAD
- Steven Kheloussi, PharmD, MBA
6:25-6:30 pm — Audience Q&A
Moderator
Continuing Education Credit — Pharmacists
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Earning CPE Credit
To earn continuing pharmacy education (CPE) credit for this program, you must attend the entire session and participate in the pre- and post-test questions.
- ACPE UAN #: 0233-0000-22-055-L01-P
- Credit: 1 Contact Hours Or 0.1 CEUs
- Activity Type: Knowledge-based
- Activity Fee: There is no fee to participate in this activity.
Innovations in Immune-Mediated Skin Conditions: Focus on Atopic Dermatitis
- Thursday, Jan. 26, 2023, 3:00–4:00 pm EST
- Thursday, Feb. 2, 2023, 3:00–4:00 pm EST (repeat offering)
During this session, presenters will provide an overview of the disease burden of atopic dermatitis, discuss management strategies for controlling health care costs and ensuring appropriate utilization, highlight the patient-specific factors considered when making treatment decisions for a diverse population, and explore the rapidly expanding treatment options and emerging pipeline for atopic dermatitis.
Learning Objectives
At the completion of this knowledge-based activity, participants should be able to:
1. Describe the disease burden of moderate-to-severe atopic dermatitis on clinical and patient-reported outcomes.
2. Differentiate new and emerging targeted therapies for atopic dermatitis based on mechanisms of action, efficacy and safety data, and indications.
3. Discuss approaches to managing atopic dermatitis among a diverse patient population.
4. Identify strategies to manage health care utilization and costs related to atopic dermatitis.
Target Audience
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
Faculty
- Junko Takeshita, MD, PhD, MSCE
Assistant Professor of Dermatology and Epidemiology
University of Pennsylvania Perelman School of Medicine - Steven Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy
Highmark Inc.
Moderators
- Kellie Rademacher, PharmD
Director Strategy
Evoke Navience - Lynn Deguzman, PharmD, BCGP
Clinical Pharmacy Services Director, National Pharmacy
Kaiser Permanente
Agenda
3:00-3:05 pm — Welcome and Introductions
Moderator
3:05-3:55 pm — Presentation: Innovations in Immune-Mediated Skin Conditions: Focus on Atopic Dermatitis
Junko Takeshita, MD, PhD, MSCE
Steven Kheloussi, PharmD, MBA
3:55-4:00 pm — Audience Q&A
Moderator
Continuing Education Credit — Pharmacists
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Earning CPE Credit
To earn continuing pharmacy education (CPE) credit for this program, you must attend the entire session and participate in the pre- and post-test questions.
-
ACPE UAN #: 0233-0000-22-056-L01-P
-
Credit: 1 Contact Hours Or 0.1 CEUs
-
Activity Type: Knowledge-based
-
Activity Fee: There is no fee to participate in this activity.
Steven S. Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy
Highmark Inc.
Steve Kheloussi is the manager of the Clinical Pharmacy Strategies (CPS) team at Highmark Inc. He is also an adjunct faculty member at Wilkes University where he teaches managed care courses in both the PharmD and the MBA programs. Steve specializes in formulary management and managed care education and has extensive experience in medication therapy management, quality and population health, utilization management, and specialty contracting and trend management. Steve currently serves on the AMCP Educational Affairs Committee and is the faculty advisor of the Wilkes University AMCP chapter. His passion for student success and engagement led him to being selected as the recipient of the 2022 AMCP Experiential Preceptor of the Year award.
Loren Krueger, MD, FAAD
Assistant Professor, Dermatology
Vice Chair, Diversity, Equity and Inclusion
Emory University School of Medicine
Dr. Loren Krueger is a medical and procedural dermatologist in Atlanta, Georgia. Her areas of expertise include hair loss disorders and Skin of Color Dermatology. She trains learners and residents through her role as Associate Program Director for the dermatology residency. She also serves as the Vice Chair for Diversity, Equity and Inclusion for the department of dermatology. She has published numerous journal articles ranging in topics from bias in dermatology to the history of hair care practices in the US.
Junko Takeshita, MD, PhD, MSCE
Assistant Professor of Dermatology
Assistant Professor of Epidemiology
University of Pennsylvania Perelman School of Medicine
Dr. Takeshita is a board-certified adult dermatologist and epidemiologist who leads an R01-funded research program that is dedicated to identifying, understanding, and eliminating health and healthcare disparities related to dermatologic diseases, particularly chronic inflammatory diseases such as atopic dermatitis, psoriasis, and acne. She uses quantitative, qualitative, and mixed methods research techniques to study health disparities and has authored many scientific publications on the topics of racial and ethnic health and healthcare disparities in psoriasis, atopic dermatitis, and acne; psoriasis comorbidities; and comparative effectiveness research in psoriasis. Dr. Takeshita is a recipient of an Outstanding New Investigator Award from the National Psoriasis Foundation, a Young Investigator Award from the American Academy of Dermatology, and a Young Physician-Scientist Award from the American Society for Clinical Investigation. She receives/has received grant funding from the National Institutes of Health, the Dermatology Foundation, the National Psoriasis Foundation, and the National Eczema Association to support her independent research program.
Lynn Deguzman, PharmD, BCGP
Clinical Pharmacy Services Director, National Pharmacy
Kaiser Permanente
Kellie Rademacher, PharmD
Director Strategy
Evoke Navience
